Yensheng Wang

14-CpG-Based Signature Improves the Prognosis Prediction of Hepatocellular Carcinoma Patients

G. Ning, Hongye Jiang, Yensheng Wang, 2020, BioMed research international.

Development of N6-methyladenosine Related Signature as New Biomarker for Prognosis of Hepatocellular Carcinoma and Correlates with Sorafenib and anti-PD-1 Immunotherapy Treatment Response

G. Ning, Hongye Jiang, Yensheng Wang, 2020 .

Transcriptional expressions of Chromobox 1/2/3/6/8 as independent indicators for survivals in hepatocellular carcinoma patients

Yanlin Huang, G. Ning, Yensheng Wang, 2018, Aging.

Identification of an m6A-Related Signature as Biomarker for Hepatocellular Carcinoma Prognosis and Correlates with Sorafenib and Anti-PD-1 Immunotherapy Treatment Response

G. Ning, Hongye Jiang, Yensheng Wang, 2021, Disease markers.

Ahypoxia-related signature enhances the prediction of the prognosis in hepatocellular carcinoma patients and correlates with sorafenib treatment response.

G. Ning, Hongye Jiang, Yensheng Wang, 2020, American journal of translational research.